Chip based single cell analysis for nanotoxicity assessment.

Area of Science:

• Nanotoxicology
• Analytical Chemistry
• Biotechnology

Background:

• Nanomaterials offer tunable properties, leading to widespread use in consumer products and technology.
• Exposure to nanomaterials beyond physiological ranges poses health risks, affecting biological functions, genomic systems, and the central nervous system.
• Current nanotoxicity assessment methods, like spectrophotometric assays, are time-consuming, prone to false positives, and lack single-cell resolution.

Purpose of the Study:

• To review traditional and novel approaches for nanotoxicity assessment.
• To highlight the limitations of conventional techniques in evaluating nanomaterial safety.
• To discuss the potential of cell-on-a-chip (CoC) integrated with microfluidics for precise nanotoxicity evaluation.

Main Methods:

• Review of existing literature on nanotoxicity assessment techniques.
• Analysis of the advantages and limitations of conventional methods (e.g., spectrophotometry).
• Exploration of microfluidic systems and cell-on-a-chip (CoC) technology for advanced nanotoxicity testing.

Main Results:

• Conventional nanotoxicity assays are often slow, inaccurate, and unsuitable for single-cell analysis.
• Microfluidic systems offer automated fluid handling and reduced human error.
• Cell-on-a-chip (CoC) integrated with microfluidics provides a promising platform for sensitive, accurate, and single-cell level nanotoxicity assessment.

Conclusions:

• There is a critical need for advanced analytical approaches for nanotoxicity assessment.
• Cell-on-a-chip (CoC) technology combined with microfluidics represents a significant advancement in nanotoxicity evaluation.
• These integrated systems offer a path towards safer use of nanomaterials in consumer products and technology.